Following antecedent hypoglycemia, miglitol (Glyset©, Pfizer, New York, NY, United States) a SGLT3 agonist, was shown to restore the counterregulatory response to hypoglycemia in rats (Jokiaho et al., 2022). This evidence concerns the gene SLC5A4 and Hypoglycemia.